Jazz Pharmaceuticals, a Zacks Rank #1 (Strong Buy), is a specialty biopharmaceutical company that identifies, develops, and ...

HC Wainwright issued their Q1 2025 earnings estimates for shares of Jazz Pharmaceuticals in a research note issued to investors on Monday, March 10th. HC Wainwright analyst O. Livnat forecasts that ...

Chicago, IL – March 12, 2025 – Zacks Equity Research shares Jazz Pharmaceuticals JAZZ as the Bull of the Day and The Boston Beer Company SAM as the Bear ...

The Statehouse is debating adding further restrictions to recreational marijuana while Gov. Mike DeWine has proposed hiking ...

The stock market selloff heated up to start the week as Wall Street locked in profits amid the chaos caused by the tariff ...

Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target upped by HC Wainwright from $200.00 to $217.00 in a ...

Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Nasdaq-listed GW is in line for $220 ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Monday, March 10, 2025. Let’s take ...

Cannabis (Cannabis sativa) is an herbal drug. It contains chemicals called cannabinoids, including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The cannabinoids in cannabis work by ...

After hours: February 28 at 7:09:46 p.m. EST ...